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AGE, DEMENTIA, AND EVIDENCE-BASED MEDICATION USE AFTER ADMISSION
FOR ACUTE CORONARY SYNDROME
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1National Taiwan University, Taipei, Taiwan, 2Taipei Medical University and Shin Kong WHS
Memorial Hospital, Taipei, Taiwan
OBJECTIVES: To assess the impact of dementia on evidence-based medication use
after admission for patients with acute coronary syndrome (ACS) across different
age groups.METHODS: Of 87,298 patients hospitalized for ACS between January 1,
2006 and December 31, 2007, 1835 patients with dementia and 3670 matched pa-
tients without dementia (1:2 ratio, matched by age, gender, and admitted hospital
level) were identified fromTaiwan’s National Health Insurance Research Database.
Use of evidence-based medications post-discharge were compared between pa-
tients with and without dementia across different age groups (65, 66-75, 76-85,
85). Multivariate logistic regression models were performed to examine the im-
pact of dementia on use of evidence-basedmedications.RESULTS:Overall, demen-
tia was associated with a 22% lower likelihood of use of evidence-based medica-
tions (adjusted odds ratio (OR)  0.78, CI0.68-0.89) in ACS patients. The use of
evidence-based medications decreased with age, and dementia worsened the uti-
lization. The proportions of patients receiving evidence-based medications were
85.6% (without dementia) versus 73.6% (with dementia) in the youngest age group
and 62.0 % (without dementia) versus 55.6% (with dementia) in the oldest age
group. CONCLUSIONS: Dementia and aging were associated with the use of evi-
dence-based medications in ACS patients.
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REAL-WORLD CHARACTERIZATION OF HYPERTENSION PATIENTS IN JAPAN: A
1-YEAR OVERVIEW
Crawford B1, Ong SH2, Falvey H2
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OBJECTIVES: To characterize the real-world profile of hypertension patients in
Japan and their treatments, BP control, and health care resource consumptionwith
a primary focus on isolated systolic hypertension (ISH) and the elderly patient
population. METHODS: Data were extracted from insurance claims and from an-
nual health examination. Only subjects who had blood pressure readings from
their annual health examinations in 2009 and 2010 at 10-14 months apart were
included. Subjects were identified by ICD-10-CM. Treatments were evaluated to
understand the current distributions with a focus on 65 versus 65 years of age.
Control rates were calculated and costs evaluated by hypertension type. RESULTS:
A total of 9269 subjects were identified with a hypertension diagnosis and annual
health exam blood pressure readings. Subjects mean age was 51.61(9.54) years old,
72.6% were male, and were diagnosed for 3.72(3.95) years. 56.24% were currently
controlled and 15.48% had ISH. Poly-pharmacy for hypertension was common
(42.49%). ARBs (47.68%) and CCBs (28.26%) were usedmost frequently. The number
of treatments subjects received increased with the number of years diagnosed,
with an average of 1.23medicationswithin the first year and 2.45 after 10 years. For
subjects controlled at baseline, 21.6% reverted to “uncontrolled” 1-year later and
47.9% ISH subjects improved “to-goal”. The average cost of treating subjects signif-
icantly differed over one year: JPY231,626.32 for “controlled” subjects,
JPY230,989.37 for ISH and isolated diastolic subjects were least expensive at
JPY141,739.55. Elderly had a significantly higher cost than subjects less than 65-
year-old (JPY266,771.28 vs JPY213,091.42). CONCLUSIONS:Hypertension in Japan is
characterized by poly-pharmacy and only moderate control. Elderly patients are
significantly more costly to treat and “controlled” and ISH patients were the most
costly to treat. Treatment was dominated by ARBs and CCBs (alone or in combina-
tion with other treatments).
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ASSOCIATION BETWEEN KNOWLEDGE AND HEALTH RELATED QUALITY OF
LIFE? IS PATIENT EDUCATION ALWAYS BENEFICIAL?
Saleem F1, Hassali MA1, Shafie AA1, Aljadhey H2, Haq N1, Atif M3
1Universiti Sains Malaysia, Penang, Malaysia, 2King Saud University, Riyadh, Riyadh, Saudi
Arabia, 3Allianze University College of Medical Sciences (AUCMS), Penang, Malaysia
OBJECTIVES: To evaluate association between HRQoL and knowledge among hy-
pertensive population of Pakistan. METHODS: A cross sectional descriptive study
was undertakenwith a representative cohort of hypertension patients. Using prev-
alence based sampling technique, a total of 385 hypertensive patients were se-
lected from two public hospitals of Quetta city, Pakistan. Hypertension Fact Ques-
tionnaire (HFQ) and European Quality of Life scale (EQ-5D) were used for data
collection. SPSS v 16.0 was used to compute descriptive analysis of patients’ demo-
graphic and disease related information. Categorical variables were described as
percentages while continuous variables were expressed as mean standard devi-
ation (SD). Spearman’s rho co-relation was used to identify the association be-
tween study variables. RESULTS: The mean (SD) age of the patients was 39.02 
(6.59), with 68.8% males (n265). The mean (SD) duration of hypertension was
3.010.93 years. Forty percent (n154) had bachelor degree with 34.8% (n134)
working in private sector. Almost forty one percent (n140) hadmonthly income of
more than 15000 Pakistan rupees (Pk Rs) per month (1 Pk Rs0.01172 US$) with
75.1% (n289) having urban residency. The mean EQ-5D descriptive score
(0.460.28) and EQ-VAS score (63.976.62) indicated lower HRQoL in our study
participants. Mean knowledge score was 8.03  0.42. Correlation coefficient be-
tween HRQoL and knowledge was 0.208 (p 0.001), indicating a week positive
association. CONCLUSIONS: Results of this study highlight hypertension knowl-
edge to be weakly associated with HRQoL suggesting that imparting knowledge to
patients do not necessarily improve HRQoL. More attention should be given to
identify individualized factors affecting HRQoL.
PODIUM SESSION II:
HEALTH CARE EXPENDITURES STUDIES
EX1
THE EFFECTS OF POLYPHARMACY ON HEALTH CARE COSTS AND HOSPITAL
ADMISSIONS IN THAI ELDERLY POPULATION: MULTIVARIATE TWO-PART
MODELS
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OBJECTIVES: Polypharmacy is a widely known risk factor for adverse drug reac-
tions, drug-drug interactions, and low adherence in the elderly population. There
remains a paucity of evidence demonstrating its effect on hospital admissions and
costs. This study aims to determine the effects of polypharmacy on hospital ad-
missions and hospital costs among older patients in Thailand.METHODS: A retro-
spective cohort study was conducted using an electronic patient database in a
provincial hospital of Thailand . All patients aged 60 years or older with at least 2
visits during 2009 were included. Exposure of interest is polypharmacy and exces-
sive polypharmacy which were defined as dispensed medications for more than
five and ten items, respectively. Outcomes of interest are hospital admissions and
hospitalization costs incurred after index date of polypharmacy. We performed
two-partmodel and used poisson regression and log-transformed linear regression
with Duan’s smearing estimator to determine the effects of polypharmacy on hos-
pital admissions rate and hospitalization costs, respectively. All analyses were
adjusted for potential confounders and propensity score. RESULTS: A total of
17,787 elderly patients were included. Themean agewas 71 years with 57% female.
Forty-two and 12 percent of patients received polypharmacy and excessive polyp-
harmacy, respectively. Excessive polypharmacy was significantly associated with
increased risk of admission (adjusted incidence rate ratio (IRR): 3.2 (95% CI; 1.1-5.4))
while only increased trend of admission was found among polypharmacy (IRR: 1.5
(95% CI; 0.9-2.1), Hospitalization costs were significantly higher at $135 (95% CI;
111.0 – 159.0) and $25.0 (95% CI; 16.1 – 38.0) for excessive polypharmacy and polyp-
harmacy, compared with non-polypharmacy. CONCLUSIONS: Both polypharmacy
and excessive polypharmacy have significantly elevated health care costs but only
excessive polypharmacy is significantly associated with increased risk of hospital
admission. These findings demonstrated the detrimental effects of polypharmacy
and highlighted the importance of finding measures to reduce polypharmacy.
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OBJECTIVES: To know the changes of outpatient clinic utilization and the prescrip-
tion numbers per each outpatient clinic visit. METHODS: This study use Longitu-
dinal Health Insurance Database(LHID) 2005 from the National Health Insurance
Research Database, it contains 1 million random samples of year 2005 Registry.
There are approximately 25.68 million individuals in this registry. The study sub-
jects were the elderly over 65 years old in each year. We had reviewed the preva-
lence of outpatient clinic visit during the year, average outpatient clinic visit per
year, medicine prescription in outpatient clinic of our study subjects. (grouped as
numbers of item prescribed; zero, one to four, five to nine and above ten items).
RESULTS: The total numbers of study subjects in each year increase from 52,672 in
1997 to 108,444 in 2010. Most of the elderly had utilized outpatient clinic, and the
percentage of clinic utilization during these years had been in a rise every year.
(93.4% in 1997 versus 96.8% in 2010). For those who had utilized at least one time
outpatient clinic resources, the average outpatient visit numbers in this study
ranges from25.6 to 31.3 times/person-year during the period. However, numbers of
prescription in each visit had decreased gradually. In 1997, the percentages of no
items prescribed, 1-4 items, 5-9 items and more than 10 items prescribed were
50.1%, 28.39%, 20.07% and 1.42% respectively. In 2010, however, the percentages
were 53.4%, 33.54%, 12.3% and 0.79% respectively.CONCLUSIONS:The prescription
numbers had decreased gradually in the study period. The utilization percentage of
outpatient clinic, however, was on a rise. In addition, multiple prescriptions (more
than 5 items) was quiet common in our study,medical care givers should paymore
attention on the issue of multiple prescription of our elderly.
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A EVALUATION OF THE EFFECTS FROM CHINA DRUG POLICY REFORM DURING
2009-2011: SOME SUCCESS, MANY UNINTENDED EFFECTS
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OBJECTIVES: Many drug policies were implemented during 2009-2011 in China in
order to lower the health cost burden from drug over-consumption and over-pric-
ing. The effects of these polices have been intensively debated at the turn of 2012 in
the mainstream media, albeit in the absence of comprehensive official statistics.
The aim of this research is to assess the outcome of the drug policy reform during
2009-2011, based on the available publications. METHODS: Drug policies issued
2009-2011 by central governmentwere identified and grouped intomutually exclu-
sive categories, based on their main targets. All relevant news reports published in
mainstream Chinese digital news portals from December 2011 to March 2012 were
gathered and analysed by health policy trained analyst familiar with Chinese
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